Company / Total Assets
Cartesian Therapeutics, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$296.4M
FY2025
5-year range
$159.9M / $435.0M
FY2021-FY2025
Trend
-31.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 8 years, ranging from $89M in FY2016 to $435M in FY2024.
Based on SEC 10-K filings.
$296M in FY2025 with a 5-year CAGR of +12.4%.
Declined from $305M to $296M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +21.3%
- 5-Year CAGR
- +12.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +12.4%, indicating consistent growth.
- In FY2025, total assets decreased 31.9% year-over-year.
- Peak total assets was recorded in FY2024.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $296.4M | -31.9% |
| FY2024 | $435.0M | +42.6% |
| FY2023 | $305.1M | +83.9% |
| FY2022 | $165.9M | +3.8% |
| FY2021 | $159.9M | -3.4% |
| FY2020 | $165.4M | +66.2% |
| FY2019 | $99.6M | +11.5% |
| FY2016 | $89.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026